Interferon Beta 1 Clinical Trial Pipeline

S. No	Title	Location	References
1	Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19	Canada	https://clinicaltrials.gov/ct2/show/NCT04354259
2	A Prospective/Retrospective, Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia	China	https://clinicaltrials.gov/ct2/show/NCT04254874
3	Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff	China	https://clinicaltrials.gov/ct2/show/NCT04320238
4	Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection	United Kingdom	https://clinicaltrials.gov/ct2/show/NCT04385095
5	Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection	Spain	https://clinicaltrials.gov/ct2/show/NCT04366245
6	Double Therapy With IFN-beta 1b and Hydroxychloroquine	Hongkong	https://clinicaltrials.gov/ct2/show/NCT04350281
7	Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection	China	https://clinicaltrials.gov/ct2/show/NCT04251871
8	Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial	Canada	https://clinicaltrials.gov/ct2/show/NCT04324463
9	Trial of Treatments for COVID-19 in Hospitalized Adults	France	https://clinicaltrials.gov/ct2/show/NCT04315948